The need to accelerate access to new drugs for multidrug-resistant tuberculosis

• Egile Nagusiak: Helen S Cox (Egilea), Jennifer J Furin (Egilea), Carole D Mitnick (Egilea), Colleen Daniels (Egilea), Vivian Cox (Egilea), Eric Goemaere (Egilea)
• Formatua: Liburua
• Argitaratua: The World Health Organization, 2015-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

AbstractApproximately half a million people are thought to develop multidrug-resistant tuberculosis annually. Barely 20% of these people currently receive recommended treatment and only about 10% are successfully treated. Poor access to treatment is probably driving the current epidemic, via ongoing...